• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RIP4 通过抑制 STAT3 信号通路来维持肺腺癌的分化。

RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation.

机构信息

Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.

Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Lausanne CH-1015, Switzerland.

出版信息

Cell Death Differ. 2017 Oct;24(10):1761-1771. doi: 10.1038/cdd.2017.81. Epub 2017 Jun 2.

DOI:10.1038/cdd.2017.81
PMID:28574510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5596425/
Abstract

Loss of epithelial differentiation and extracellular matrix (ECM) remodeling are known to facilitate cancer progression and are associated with poor prognosis in patients with lung cancer. We have identified Receptor-interacting serine/threonine protein kinase 4 (RIP4) as a regulator of tumor differentiation in lung adenocarcinoma (AC). Bioinformatics analyses of human lung AC samples showed that poorly differentiated tumors express low levels of RIP4, whereas high levels are associated with better overall survival. In vitro, lung tumor cells expressing reduced RIP4 levels showed enhanced activation of STAT3 signaling and had a greater ability to invade through collagen. In contrast, overexpression of RIP4 inhibited STAT3 activation, which abrogated interleukin-6-dependent induction of lysyl oxidase, a collagen cross-linking enzyme. In an autochthonous mouse model of lung AC initiated by Kras(G12D) expression with loss of p53, Rip4 knockdown tumors progressed to a poorly differentiated state marked by an increase in Hmga2, reduced Ttf1, and enrichment of genes regulating extracellular remodeling and Jak-Stat signaling. Tail vein injections of cells overexpressing Rip4 showed a reduced potential to invade and form tumors, which was restored by co-expression of Stat3. Altogether, our work has identified that loss of RIP4 enhances STAT3 signaling in lung cancer cells, promoting the expression of ECM remodeling genes and cancer dedifferentiation.

摘要

上皮分化丧失和细胞外基质(ECM)重塑已知可促进癌症进展,并与肺癌患者的预后不良相关。我们已经确定受体相互作用丝氨酸/苏氨酸蛋白激酶 4(RIP4)是肺腺癌(AC)肿瘤分化的调节剂。对人类肺 AC 样本的生物信息学分析表明,分化不良的肿瘤表达低水平的 RIP4,而高水平与更好的总生存率相关。在体外,表达低水平 RIP4 的肺肿瘤细胞显示出 STAT3 信号的增强激活,并且具有更强的穿过胶原蛋白侵袭的能力。相比之下,RIP4 的过表达抑制了 STAT3 的激活,从而阻断了白细胞介素 6 依赖性赖氨酰氧化酶的诱导,赖氨酰氧化酶是一种胶原蛋白交联酶。在 Kras(G12D)表达伴有 p53 缺失引发的肺 AC 自发小鼠模型中,Rip4 敲低肿瘤进展为低分化状态,其特征是 Hmga2 增加、Ttf1 减少以及调节细胞外重塑和 Jak-Stat 信号的基因富集。过表达 Rip4 的细胞的尾静脉注射显示出侵袭和形成肿瘤的潜力降低,这可通过共表达 Stat3 来恢复。总之,我们的工作已经确定,RIP4 的缺失增强了肺癌细胞中的 STAT3 信号,促进了 ECM 重塑基因和癌症去分化的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/db3646f93f60/cdd201781f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/1bde2902131e/cdd201781f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/08d7e619899a/cdd201781f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/4cb646ab0901/cdd201781f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/c6014b4ff26b/cdd201781f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/db3646f93f60/cdd201781f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/1bde2902131e/cdd201781f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/08d7e619899a/cdd201781f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/4cb646ab0901/cdd201781f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/c6014b4ff26b/cdd201781f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5daa/5596425/db3646f93f60/cdd201781f5.jpg

相似文献

1
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation.RIP4 通过抑制 STAT3 信号通路来维持肺腺癌的分化。
Cell Death Differ. 2017 Oct;24(10):1761-1771. doi: 10.1038/cdd.2017.81. Epub 2017 Jun 2.
2
RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes.RIP4 通过 STAT3 信号通路上调角质形成细胞中 CCL20 的表达。
Exp Dermatol. 2018 Oct;27(10):1126-1133. doi: 10.1111/exd.13750. Epub 2018 Aug 22.
3
RIP4 is a target of multiple signal transduction pathways in keratinocytes: implications for epidermal differentiation and cutaneous wound repair.RIP4 是角质细胞中多种信号转导通路的靶标:对表皮分化和皮肤创伤修复的意义。
Exp Cell Res. 2010 Jan 1;316(1):126-37. doi: 10.1016/j.yexcr.2009.10.006. Epub 2009 Oct 8.
4
RIP4 regulates epidermal differentiation and cutaneous inflammation.RIP4 调节表皮分化和皮肤炎症。
J Invest Dermatol. 2010 Jan;130(1):102-12. doi: 10.1038/jid.2009.223.
5
Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.阻断白细胞介素-6 转导/STAT3 轴可抑制 Kras 诱导的肺腺癌恶病质。
Oncogene. 2017 May 25;36(21):3059-3066. doi: 10.1038/onc.2016.437. Epub 2016 Nov 28.
6
RIP4 is an ankyrin repeat-containing kinase essential for keratinocyte differentiation.RIP4是一种含锚蛋白重复序列的激酶,对角质形成细胞分化至关重要。
Curr Biol. 2002 Aug 20;12(16):1424-8. doi: 10.1016/s0960-9822(02)01075-8.
7
Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.ERK的激活以及Stat3和SP1的相互调节有助于白术内酯-1对人肺癌细胞中PDK1表达的抑制作用。
Cell Physiol Biochem. 2017;43(6):2353-2366. doi: 10.1159/000484387. Epub 2017 Oct 27.
8
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.S100A7促进肺腺癌向鳞癌的转分化,并且其表达在肺癌细胞中受Hippo-YAP信号通路的差异调控。
Oncotarget. 2017 Apr 11;8(15):24804-24814. doi: 10.18632/oncotarget.15063.
9
Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.肺腺癌起始和进展过程中MAPK信号放大的上下文依赖性效应
Cell Rep. 2017 Feb 21;18(8):1958-1969. doi: 10.1016/j.celrep.2017.01.069.
10
ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma.锌指蛋白32通过调节肺腺癌中转化生长因子-β受体2信号通路促进多药耐药的诱导。
Cell Death Dis. 2016 Oct 20;7(10):e2428. doi: 10.1038/cddis.2016.328.

引用本文的文献

1
The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells.RIPK4在肿瘤坏死因子-α刺激黑色素瘤细胞产生白细胞介素-6和白细胞介素-8中的作用。
J Cancer Res Clin Oncol. 2024 Apr 24;150(4):209. doi: 10.1007/s00432-024-05732-3.
2
miR-575/RIPK4 axis modulates cell cycle progression and proliferation by inactivating the Wnt/β-catenin signaling pathway through inhibiting RUNX1 in colon cancer.miR-575/RIPK4 轴通过抑制 RUNX1 使 Wnt/β-连环蛋白信号通路失活,从而调节结肠癌中的细胞周期进程和增殖。
Mol Cell Biochem. 2024 Jul;479(7):1747-1766. doi: 10.1007/s11010-024-04938-w. Epub 2024 Mar 14.
3

本文引用的文献

1
Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells.PP2A-STAT3-ColXVII 介导的悬浮存活决定了癌症干细胞中的肿瘤起始和转移。
Nat Commun. 2016 Jun 16;7:11798. doi: 10.1038/ncomms11798.
2
Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.P53 功能丧失激活 JAK2-STAT3 信号通路,促进小鼠胰腺肿瘤生长、基质修饰和吉西他滨耐药,并与患者生存相关。
Gastroenterology. 2016 Jul;151(1):180-193.e12. doi: 10.1053/j.gastro.2016.03.010. Epub 2016 Mar 19.
3
Functions of the RIP kinase family members in the skin.
RIP 激酶家族成员在皮肤中的功能。
Cell Mol Life Sci. 2023 Sep 9;80(10):285. doi: 10.1007/s00018-023-04917-2.
4
Vemurafenib and Dabrafenib Downregulates RIPK4 Level.维莫非尼和达拉非尼下调RIPK4水平。
Cancers (Basel). 2023 Feb 1;15(3):918. doi: 10.3390/cancers15030918.
5
Increased Expression of the Δ133p53β Isoform Enhances Brain Metastasis.Δ133p53β 异构体表达增加增强脑转移。
Int J Mol Sci. 2023 Jan 9;24(2):1267. doi: 10.3390/ijms24021267.
6
Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer.赖氨酰氧化酶家族蛋白:癌症的潜在治疗靶点。
Int J Mol Sci. 2022 Oct 14;23(20):12270. doi: 10.3390/ijms232012270.
7
Role of Receptor Interacting Protein (RIP) kinases in cancer.受体相互作用蛋白(RIP)激酶在癌症中的作用。
Genes Dis. 2021 Nov 18;9(6):1579-1593. doi: 10.1016/j.gendis.2021.10.007. eCollection 2022 Nov.
8
The RIPK family: expression profile and prognostic value in lung adenocarcinoma.RIPK 家族:肺腺癌中的表达谱和预后价值。
Aging (Albany NY). 2022 Jul 30;14(14):5946-5958. doi: 10.18632/aging.204195.
9
Depletion of RIPK4 parallels higher malignancy potential in cutaneous squamous cell carcinoma.RIPK4 的耗竭与皮肤鳞状细胞癌更高的恶性潜能平行。
PeerJ. 2022 Feb 10;10:e12932. doi: 10.7717/peerj.12932. eCollection 2022.
10
Developing prognostic gene panel of survival time in lung adenocarcinoma patients using machine learning.利用机器学习开发肺腺癌患者生存时间的预后基因panel。
Transl Cancer Res. 2020 Jun;9(6):3860-3869. doi: 10.21037/tcr-19-2739.
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis.
IL6 转信号促进 KRAS 驱动的肺癌发生。
Cancer Res. 2016 Feb 15;76(4):866-76. doi: 10.1158/0008-5472.CAN-15-2388. Epub 2016 Jan 7.
4
Constitutive activation of STAT3 in breast cancer cells: A review.乳腺癌细胞中STAT3的组成性激活:综述
Int J Cancer. 2016 Jun 1;138(11):2570-8. doi: 10.1002/ijc.29923. Epub 2015 Nov 28.
5
Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.PAFR 和 STAT3 的前馈相互激活调节非小细胞肺癌中的上皮-间充质转化。
Cancer Res. 2015 Oct 1;75(19):4198-210. doi: 10.1158/0008-5472.CAN-15-1062. Epub 2015 Sep 10.
6
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.缺氧癌细胞分泌组通过赖氨酰氧化酶诱导骨转移前病变。
Nature. 2015 Jun 4;522(7554):106-110. doi: 10.1038/nature14492. Epub 2015 May 27.
7
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.信号转导和转录激活因子3(STAT3)信号通路的破坏促进KRAS诱导的肺癌发生。
Nat Commun. 2015 Mar 3;6:6285. doi: 10.1038/ncomms7285.
8
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
9
limma powers differential expression analyses for RNA-sequencing and microarray studies.limma为RNA测序和微阵列研究提供差异表达分析的动力。
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.
10
Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.NF-κB 上调激活素是维持非小细胞肺癌中癌症干细胞样细胞间充质特征所必需的。
Cancer Res. 2015 Jan 15;75(2):426-35. doi: 10.1158/0008-5472.CAN-13-2702. Epub 2014 Nov 28.